Date published: 2026-6-5

1-800-457-3801

SCBT Portrait Logo
Seach Input

MYH7 Activators

MYH7, also known as myosin heavy chain 7, is a vital protein predominantly expressed in cardiac muscle tissue, where it serves a pivotal role in the contractile machinery of the heart. Within the sarcomeres of cardiac muscle cells, MYH7 functions as a molecular motor that drives muscle contraction by converting chemical energy into mechanical force. This process occurs through the interaction between MYH7 and actin filaments, facilitated by the hydrolysis of ATP. MYH7 contains an ATPase domain that catalyzes the hydrolysis of ATP to ADP and inorganic phosphate, releasing energy that powers the movement of myosin along actin filaments. This movement results in the sliding of actin and myosin filaments relative to each other, leading to muscle contraction. Thus, MYH7 plays a fundamental role in the rhythmic contraction and relaxation of cardiac muscle, which is essential for maintaining proper heart function and facilitating blood circulation throughout the body.

Activation of MYH7 occurs through intricate regulatory mechanisms that modulate its enzymatic activity and interaction with actin filaments. One key regulatory mechanism involves the phosphorylation of MYH7 and its associated regulatory proteins. Phosphorylation, typically mediated by protein kinases, alters the conformation and activity of MYH7, enhancing its interaction with actin and promoting muscle contraction. Additionally, changes in intracellular calcium levels play a crucial role in activating MYH7. Calcium ions bind to regulatory proteins such as troponin and tropomyosin, facilitating the exposure of binding sites on actin filaments and promoting the interaction with myosin, including MYH7. This calcium-dependent mechanism allows for precise control of muscle contraction in response to neural and hormonal signals. Overall, the activation of MYH7 is tightly regulated and coordinated to ensure efficient and synchronized contraction of cardiac muscle, thereby maintaining optimal cardiac function.

SEE ALSO...

Product NameCAS #Catalog #QUANTITYPriceCitationsRATING

Forskolin

66575-29-9sc-3562
sc-3562A
sc-3562B
sc-3562C
sc-3562D
5 mg
50 mg
1 g
2 g
5 g
$78.00
$153.00
$740.00
$1413.00
$2091.00
73
(3)

Increases cAMP levels, which can activate MYH7 via protein kinase A.

(−)-Epinephrine

51-43-4sc-205674
sc-205674A
sc-205674B
sc-205674C
sc-205674D
1 g
5 g
10 g
100 g
1 kg
$41.00
$104.00
$201.00
$1774.00
$16500.00
(1)

Acts on adrenergic receptors to induce MYH7 gene expression.

8-Bromo-cAMP

76939-46-3sc-201564
sc-201564A
10 mg
50 mg
$126.00
$328.00
30
(1)

A cAMP analog that can activate PKA, which in turn can activate MYH7.

Dexamethasone

50-02-2sc-29059
sc-29059B
sc-29059A
100 mg
1 g
5 g
$91.00
$139.00
$374.00
36
(1)

Glucocorticoid that induces MYH7 expression via glucocorticoid receptor signaling.

1α,25-Dihydroxyvitamin D3

32222-06-3sc-202877B
sc-202877A
sc-202877C
sc-202877D
sc-202877
50 µg
1 mg
5 mg
10 mg
100 µg
$220.00
$645.00
$1000.00
$1500.00
$440.00
32
(2)

Vitamin D3 metabolite that can induce MYH7 expression.

L-3,3′,5-Triiodothyronine, Sodium Salt

55-06-1sc-205725
250 mg
$115.00
(1)

Modulates gene expression including MYH7 through thyroid hormone receptors.

Insulin

11061-68-0sc-29062
sc-29062A
sc-29062B
100 mg
1 g
10 g
$156.00
$1248.00
$12508.00
82
(1)

Activates PI3K/Akt pathway, influencing MYH7 gene expression.

Retinoic Acid, all trans

302-79-4sc-200898
sc-200898A
sc-200898B
sc-200898C
500 mg
5 g
10 g
100 g
$66.00
$325.00
$587.00
$1018.00
28
(1)

Regulates MYH7 through the activation of retinoic acid receptors.

2,4-Dinitrophenol, wetted

51-28-5sc-238345
250 mg
$59.00
2
(1)

Increases metabolic demand, indirectly leading to MYH7 activation.

Genistein

446-72-0sc-3515
sc-3515A
sc-3515B
sc-3515C
sc-3515D
sc-3515E
sc-3515F
100 mg
500 mg
1 g
5 g
10 g
25 g
100 g
$45.00
$164.00
$200.00
$402.00
$575.00
$981.00
$2031.00
46
(1)

Tyrosine kinase inhibitor that can regulate muscle gene expression including MYH7.